Triple-Crown: The NSA, 3x More IDR Victories, and TrumpRx Roll-Out

Join The Phia Group’s expert panel as we deliver an informative and energetic deep dive into the No Surprises Act (NSA), the federal Independent Dispute Resolution (IDR) process, and how plans can triple their success rate in arbitration. This session will unpack the latest NSA developments, eye-opening IDR trends, and The Phia Group’s own track record – achieving a ~50% plan win rate, compared to the ~16% national average – illustrating how smart strategies can turn the tables. Attendees will gain actionable insights on eligibility screening, QPA methodology compliance, and repeat-billing provider strategies that drive better outcomes. We’ll also provide a brief political and regulatory update on the official launch of TrumpRx, PBM transparency, and other key developments affecting self-funded plans. Expect practical tips, real-world data, and zero fluff – all designed to empower your team to navigate NSA and IDR challenges with confidence.